Highlights Willow Biosciences Inc. OTC Markets

Equities

CANSF

CA97111B4047

Delayed OTC Markets Other stock markets 14:40:33 24/05/2024 BST			5-day change	1st Jan Change
0.0593 ^USD	-8.40%		-6.61%	-15.16%

05-13	Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	MT
05-13	Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	05-13	MT
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Willow Biosciences Narrows 2023 Loss YOY	04-01	MT
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Willow Biosciences Announces Second Strategic Investment From Kalsec	03-01	MT
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	01-31	MT
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	01-31	CI
Willow Biosciences Announces Collaboration with Active Pharmaceutical Ingredient Manufacturer to Manufacture More Sustainable, Cost-Effective Manufacturing Route for Their Largest Product Sold Globally	01-31	CI
Willow Biosciences Announces Collaboration With Enterin	01-16	MT
Willow Biosciences Inc. Announces Collaboration with Enterin, Inc. to Develop Sustainable Interimates and Active Pharmaceutical Ingredients	01-16	CI
Willow Biosciences Highlights Growth Plans for 2024, Provides 2023 Highlights	01-10	MT
Willow Biosciences Brief: Says Plans For "Significant" Growth In 2024	01-10	MT
Willow Biosciences and Nasdaq-listed Biopharma Co Advancing Development Program	12-07	MT
Willow Biosciences Brief: Willow and a Nasdaq-listed biopharma company Advancing Development Program	12-07	MT
Willow Biosciences Reports Q3 Results, Provides Update	11-15	MT
Willow Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Aurora Cannabis Announcing Settlement of Patent Litigation	24/10/23	MT
Willow Biosciences and Suanfarma Detail Collaboration	03/10/23	MT
Willow Biosciences Inc. and Suanfarma Announce Collaboration on Development of Large Volume Anti-Infective API Through Precision Fermentation	03/10/23	CI
Willow Biosciences Announced Completion of R&D Program on Cost Effective, Sustainably Produced UDCA	06/09/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Willow Biosciences Inc. OTC Markets

Equities

CANSF

CA97111B4047

Highlights

Filters